Zika Virus at IPHC 2027

Zika virus, a mosquito-borne infection, gained global attention due to its rapid spread and potential impact on public health. The virus is primarily transmitted by Aedes mosquitoes, the same vectors responsible for dengue and chikungunya. First identified in the Zika Forest of Uganda in 1947, human cases were relatively rare until a significant outbreak occurred in the Pacific Island of Yap in 2007. However, the most notable outbreak emerged in the Americas in 2015, raising concerns about its association with neurological complications, particularly microcephaly in newborns. Symptoms of Zika virus infection are generally mild, including fever, rash, joint pain, and conjunctivitis. However, the potential link to birth defects and neurological disorders led to heightened awareness and public health responses. Preventive measures for Zika virus involve mosquito control strategies, such as eliminating breeding sites and using insect repellent. Pregnant women or those planning to conceive are advised to take extra precautions due to the potential impact on fetal development. While Zika virus transmission has decreased since its peak in 2016, ongoing surveillance remains essential. Research continues to enhance our understanding of the virus and develop potential vaccines. Zika virus exemplifies the dynamic nature of communicable diseases and the importance of global collaboration in monitoring, responding to, and controlling emerging infectious threats.